Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
about
Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsAn albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug deliveryConjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery.Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.Modulation of Ligand Fluorescence by the Pt(II)/Pt(IV) Redox Couple.Acetate-bridged platinum(III) complexes derived from cisplatin.Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformationsMonofunctional and higher-valent platinum anticancer agents.Synthetic methods for the preparation of platinum anticancer complexes.Interstrand DNA covalent binding of two dinuclear Ru(ii) complexes. Influence of the extra ring of the bridging ligand on the DNA interaction and cytotoxic activity.Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low ToxicityInfluence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin.Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands.Accurate prediction of 195Pt NMR chemical shifts for a series of Pt(II) and Pt(IV) antitumor agents by a non-relativistic DFT computational protocol.
P2860
Q27011482-E06DE9EC-23E5-4DE8-9DB6-DE944253B11EQ28066801-87743650-30ED-4813-837A-CEFED3C93963Q33615268-A17CD9CB-3FE7-4E35-94FB-857376F029E3Q33825880-9C0AFB70-3F76-41D7-A0A1-F71C31840FFBQ34060461-DD2BF064-B720-4AB1-97CD-C1BD5ABECDF5Q35000093-537B5A2C-00D9-493E-B7C1-E05EA9E09967Q35334366-2C293D5E-B3D5-4E03-876B-A30AAAD5ADCFQ36111844-865E33BD-C567-4C20-B2FD-0400C8C6159FQ36277805-D523A938-5923-4454-9543-65CBDEAF139BQ37239268-698CAC63-0E8A-4599-9166-A46A9B93727FQ37282213-B2CC7BD4-5FB5-4E2A-B5BC-FB0D6DC2FA03Q37722632-5733418C-29BD-4BE7-8FD6-9D26C23AD2A6Q38714551-479FB365-4785-492D-A779-73EC6127B0E9Q38724009-4C18661A-148B-4028-A8D2-17E52B700F64Q38762779-DF8A3069-7C7A-4E42-8CB7-E8453B204CB1Q38886580-581A3A07-4A97-4758-870D-DCC81E6DC9C2Q39278942-29C7B25D-C3C8-4F3E-8CB1-6D62C4E9DBD2Q39298980-F9B3CAF0-718B-4AA1-848E-29EEDD5E4FB3Q41132341-32C5E671-904D-4494-8192-E2166CF73595Q41212195-2408AABC-33C7-4F86-AE35-B78EE5A95AF2Q43051494-97011DC1-B708-4818-A824-52E9B2552A0CQ44280069-F7A30978-23FA-476B-87F4-1AC37CD6704CQ46933039-B79BAE6B-FEE1-4F13-A0A7-00D7323C2D3E
P2860
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@ast
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@en
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@nl
type
label
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@ast
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@en
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@nl
prefLabel
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@ast
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@en
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@nl
P2860
P356
P1433
P1476
Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes
@en
P2093
Justin J Wilson
P2860
P304
P356
10.1021/IC2000816
P407
P577
2011-03-01T00:00:00Z